Zai Lab Ltd
ZLAB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001704292
In the last 90 days, Zai Lab Ltd insiders filed 1 open-market purchase and 4 sales; 92 institutions reported holding it in 13F filings for Q2 2026, worth $819.0M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Zai Lab Ltd changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 166 | 1 | 171 | +6 |
| Shares | 60.2M | 5 | 59.3M | −883.7K (−1.5%) |
| Value | $2.09B | $0 | $2.03B | −$61.6M (−2.9%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Zai Lab Ltd at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Avidity Partners Management LP | 1,234,000 | $42.2M | 0.92% |
| Prince Street Capital Management LLC | 74,500 | $2.55M | 6.32% |
| Susquehanna International Group, LLP | 63,467 | $2.17M | 0.00% |
| WealthPlan Investment Management, LLC | 39,393 | $1.30M | 0.09% |
| Bellevue Group AG | 36,600 | $1.28M | 0.02% |
| State of Wisconsin Investment Board | 25,253 | $864.0K | 0.00% |
| PFM Health Sciences, LP | 23,612 | $808.0K | 0.03% |
| UBS Oconnor LLC | 15,700 | $537.0K | 0.01% |
| Jane Street Group, LLC | 14,863 | $508.0K | 0.00% |
| Virtu Financial LLC | 14,544 | $497.0K | 0.05% |
| Susquehanna Fundamental Investments, LLC | 11,436 | $391.0K | 0.01% |
| Twinbeech Capital LP | 10,884 | $372.0K | 0.01% |
| Central Asset Investments & Management Holdings (HK) Ltd | 9,500 | $324.0K | 0.66% |
| Prudential PLC | 6,386 | $218.0K | 0.00% |
| ProShare Advisors LLC | 5,855 | $200.0K | 0.00% |
| Activest Wealth Management | 1,333 | $46.0K | 0.01% |
| EverSource Wealth Advisors, LLC | 810 | $28.0K | 0.01% |
| IFP Advisors, Inc | 1,000 | $24.0K | 0.00% |
| China Universal Asset Management Co., Ltd. | 650 | $22.0K | 0.01% |
| US Bancorp | 10 | $0 | 0.00% |
Sold out (14)
Institutions that held Zai Lab Ltd at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Baillie Gifford & Co | 737,152 | $25.5M |
| Integral Health Asset Management, LLC | 156,554 | $5.43M |
| Citadel Advisors LLC | 79,043 | $2.74M |
| Cubist Systematic Strategies, LLC | 72,258 | $2.51M |
| Connective Portfolio Management, LLC | 20,000 | $694.0K |
| Boothbay Fund Management, LLC | 9,960 | $345.0K |
| Bayesian Capital Management, LP | 9,100 | $316.0K |
| Ikarian Capital, LLC | 81,843 | $278.0K |
| Nomura Holdings Inc | 6,568 | $227.0K |
| Fisher Asset Management, LLC | 5,777 | $200.0K |
| Gyon Technologies Capital Management, LP | 5,780 | $200.0K |
| Knights of Columbus Asset Advisors LLC | 1,006 | $35.0K |
| Pinebridge Investments, L.P. | 342 | $12.0K |
| Harbor Investment Advisory, LLC | 226 | $8.00K |
Not filed for Q3 2022 yet (1)
Institutions that held Zai Lab Ltd at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Fieldpoint Private Securities, LLC | 5 | $0 |